Carmat Financial Statements From 2010 to 2024

CXT Stock  EUR 1.12  0.04  3.45%   
Carmat SA financial statements provide useful quarterly and yearly information to potential Carmat SA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Carmat SA financial statements helps investors assess Carmat SA's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Carmat SA's valuation are summarized below:
Carmat SA does not presently have any fundamental signals for analysis.
Check Carmat SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Carmat SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Carmat financial statements analysis is a perfect complement when working with Carmat SA Valuation or Volatility modules.
  
This module can also supplement various Carmat SA Technical models . Check out the analysis of Carmat SA Correlation against competitors.

Carmat SA Company Current Valuation Analysis

Carmat SA's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Carmat SA Current Valuation

    
  213.74 M  
Most of Carmat SA's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Carmat SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Carmat SA has a Current Valuation of 213.74 M. This is 98.51% lower than that of the Healthcare sector and 97.66% lower than that of the Medical Instruments & Supplies industry. The current valuation for all Germany stocks is 98.71% higher than that of the company.

Carmat SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Carmat SA's current stock value. Our valuation model uses many indicators to compare Carmat SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Carmat SA competition to find correlations between indicators driving Carmat SA's intrinsic value. More Info.
Carmat SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Carmat SA's earnings, one of the primary drivers of an investment's value.

About Carmat SA Financial Statements

Carmat SA stakeholders use historical fundamental indicators, such as Carmat SA's revenue or net income, to determine how well the company is positioned to perform in the future. Although Carmat SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in Carmat SA's assets and liabilities are reflected in the revenues and expenses on Carmat SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Carmat SA. Please read more on our technical analysis and fundamental analysis pages.
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. The company was founded in 2008 and is based in Vlizy-Villacoublay, France. CARMAT EO operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 119 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Carmat Stock

Carmat SA financial ratios help investors to determine whether Carmat Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carmat with respect to the benefits of owning Carmat SA security.